Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food ...
These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...
2hon MSN
Replit no-code review
Efficient no-code solution with its own IDE for easier development.
A SimpleHelp authentication flaw is being exploited to deploy Djinn Stealer, a cross-platform malware targeting cloud, ...
Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...
Nextcloud CEO: Open source moves from 'a nerdy audience' to the geopolitical stage Frank Karlitschek, head of the German software vendor, talked about the company’s decision to help develop the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results